Related Experiment Videos
Biologic therapy for psoriasis: a brief history, I
W D Tutrone1, M H Kagen, J Barbagallo
1Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, New York 10025, USA.
Cutis
|January 5, 2002
Summary
This review explores early biologic therapies for psoriasis, focusing on immunotherapy like peptide T and anti-CD4 antibodies. These pioneering studies established a basis for current biologic treatments for psoriasis.
Area of Science:
- Immunodermatology
- Biologic Therapies
- Psoriasis Treatment
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Biologic therapy represents a significant advancement in psoriasis treatment.
- Early research explored immunotherapy for managing psoriasis.
Purpose of the Study:
- To review pioneering clinical trials of biologic therapies for psoriasis.
- To summarize the research, procedures, results, and side effects of early immunotherapies.
- To establish a foundation for future biologic therapy research in psoriasis.
Main Methods:
- Review of early clinical trials in biologic therapy for psoriasis.
- Examination of immunotherapies including peptide T, anti-CD4 antibody (OKTcdr4a and hIgG1-CD4), and anti-Tac.
- Analysis of study procedures, outcomes, and observed side effects.
Main Results:
- Early immunotherapy trials provided valuable data on treatment efficacy and safety.
- Specific agents like peptide T and anti-CD4 antibodies were investigated.
- Results from these studies informed the development of subsequent biologic treatments.
Conclusions:
- Pioneering immunotherapy studies laid the groundwork for modern biologic treatments for psoriasis.
- Understanding early research is crucial for appreciating the evolution of psoriasis care.
- Further exploration of biologic therapy is supported by these foundational findings.